当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析 - 现金流量表

昆药集团

(600422)

  

流通市值:102.72亿  总市值:102.72亿
流通股本:7.57亿   总股本:7.57亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,438,368,562.353,789,337,884.731,625,293,351.578,175,598,178.24
  收到的税费返还5,920,295.844,626,766.5611,535,774.6313,033,968.75
  收到其他与经营活动有关的现金212,104,505.34192,196,783.5470,260,953.62471,737,335.99
  经营活动现金流入小计5,656,393,363.533,986,161,434.831,707,090,079.828,660,369,482.98
  购买商品、接受劳务支付的现金2,887,469,504.62,022,292,823.61,027,979,308.894,101,535,338.49
  支付给职工以及为职工支付的现金623,827,170.27438,823,095.97265,473,815.55765,320,326.7
  支付的各项税费501,768,910.02332,396,668.65167,314,871.87746,339,508.07
  支付其他与经营活动有关的现金1,467,164,111.4973,817,890.26385,768,512.242,239,108,669.02
  经营活动现金流出小计5,480,229,696.293,767,330,478.481,846,536,508.557,852,303,842.28
  经营活动产生的现金流量净额176,163,667.24218,830,956.35-139,446,428.73808,065,640.7
二、投资活动产生的现金流量:
  收回投资收到的现金2,611,402,378.591,288,418,692.36622,379,748.73,139,812,168.96
  取得投资收益收到的现金31,314,002.635,302,749.062,799,839.6215,595,092.95
  处置固定资产、无形资产和其他长期资产收回的现金净额1,129,438.081,120,845.541,047,619.3951,801.86
  投资活动现金流入小计2,643,845,819.31,294,842,286.96626,227,207.713,155,459,063.77
  购建固定资产、无形资产和其他长期资产支付的现金58,025,860.5426,325,967.7313,248,028.7379,431,061.47
  投资支付的现金4,060,700,0002,630,700,0001,656,700,0002,990,000,000
  投资活动现金流出小计4,118,725,860.542,657,025,967.731,669,948,028.733,069,431,061.47
  投资活动产生的现金流量净额-1,474,880,041.24-1,362,183,680.77-1,043,720,821.0286,028,002.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金---800,000
  其中:子公司吸收少数股东投资收到的现金---800,000
  取得借款收到的现金1,392,199,133.631,253,539,493.46953,621,441.38777,423,490.64
  收到其他与筹资活动有关的现金---2,098,453,119.99
  筹资活动现金流入小计1,392,199,133.631,253,539,493.46953,621,441.382,876,676,610.63
  偿还债务支付的现金505,569,385.28348,496,701.7894,620,773.47842,630,880.37
  分配股利、利润或偿付利息支付的现金258,056,625.1222,152,893.169,950,596.42186,524,936.25
  其中:子公司支付给少数股东的股利、利润---13,980,000
  支付其他与筹资活动有关的现金742,386,933.71729,282,140.27722,141,297.861,975,510,861.56
  筹资活动现金流出小计1,506,012,944.111,099,931,735.21826,712,667.753,004,666,678.18
  筹资活动产生的现金流量净额-113,813,810.48153,607,758.25126,908,773.63-127,990,067.55
四、汇率变动对现金及现金等价物的影响711,822.521,028,421.1235,093.62987,451.2
五、现金及现金等价物净增加额-1,411,818,361.96-988,716,545.05-1,056,223,382.5767,091,026.65
  加:期初现金及现金等价物余额2,133,924,411.772,133,924,411.772,133,924,411.771,366,833,385.12
  期末现金及现金等价物余额722,106,049.811,145,207,866.721,077,701,029.272,133,924,411.77
补充资料:
  净利润-249,920,820.76-751,220,665.56
  资产减值准备-4,752,967.11-21,954,873.58
  固定资产和投资性房地产折旧-55,206,137.69-114,594,168.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-55,206,137.69-114,594,168.92
  无形资产摊销-28,142,459.46-59,884,434.52
  长期待摊费用摊销-3,872,144.43-10,337,851.93
  处置固定资产、无形资产和其他长期资产的损失-757.86--1,012,610.84
  固定资产报废损失--496,561.76-54,302.23
  公允价值变动损失--1,445,663.76--6,915,856.46
  财务费用-27,472,873.34-24,268,314.16
  投资损失-694,593.72--14,933,233.77
  递延所得税--29,230,675.45-8,208,773.19
  其中:递延所得税资产减少--27,995,899.32-10,843,564.16
    递延所得税负债增加--1,234,776.13--2,634,790.97
  存货的减少-78,098,571.92-271,851,735.92
  经营性应收项目的减少-182,962,263.19-41,815,890.73
  经营性应付项目的增加--400,859,574.05--543,890,861.21
  不涉及现金收支的投资和筹资活动金额其他项目---756,147,365.29
  现金的期末余额-1,090,511,562.96-2,133,924,411.77
  减:现金的期初余额-2,133,924,411.77-1,366,833,385.12
  加:现金等价物的期末余额-54,696,303.76--
  现金及现金等价物的净增加额--988,716,545.05-767,091,026.65
公告日期2025-10-252025-08-162025-04-292025-03-12
审计意见(境内)标准无保留意见
TOP↑